Pro-convulsant effects of oral melatonin in neurologically disabled children

Lancet

Volumn 351, Issue 9111, 1998, Pages 1254-

  Sheldon, Stephen H ^a  

^a CHILDREN'S MEMORIAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MELATONIN;

ADOLESCENT; ADULT; ARTICLE; CHILD; CLINICAL ARTICLE; CLINICAL TRIAL; CONVULSION; ELECTROENCEPHALOGRAM; HUMAN; INFANT; ORAL DRUG ADMINISTRATION; POLYSOMNOGRAPHY; PRIORITY JOURNAL; SLEEP DISORDER; TREATMENT OUTCOME;

EID: 18144441631     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(05)79321-1     Document Type: Article

References (5)

1. 1 Jan J, Espenzel H, Appleton RE. The treatment of sleep disorders with melatonin. Dev Med Child Neurol 1994; 36: 97-101.
2. 2 Acuna-Castroviejo D, Escames G, Macias M, et al. Cell protective role of melatonin in the brain. J Pineal Res 1995; 19: 57-63.
3. 3 Manev H, Uz T, Kharlamov A, Joo JY. Increased brain damage after stroke or excitotoxic seizures in melatonin-deficient rates. FASAB J 1996; 10: 1546-51.
4. 4 Golombek DA, Fernandez-Duque D, DeBrito-Sanchez MG, Burin L, Cardinali DP. Time-dependent anticonvulsant activity of melatonin in hamsters. Eur J Pharmacol 1992; 210: 253-58.
5. 5 Fariello RG, Bubenik GA, Brown GM, Gorta LJ. Epileptogenic action of intraventricularly injected antimelatonin antibody. Neurology 1977; 27: 267-70.